Derek Louis Sammann - 15 Mar 2026 Form 4 Insider Report for CME GROUP INC. (CME)

Signature
By: Margaret Austin Wright For: Derek Louis Sammann
Issuer symbol
CME
Transactions as of
15 Mar 2026
Net transactions value
$0
Form type
4
Filing time
17 Mar 2026, 12:23:30 UTC
Previous filing
21 Nov 2025

Key filing fact

Derek Louis Sammann filed Form 4 for CME GROUP INC. (CME) on 17 Mar 2026.

Key facts

  • This page summarizes Derek Louis Sammann's Form 4 filing for CME GROUP INC. (CME).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Filing timestamp: 17 Mar 2026, 12:23.

Change

  • Previous filing in this sequence was filed on 21 Nov 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

CIK 0001475318 Primary reporting owner

Sammann Derek

Relationship
Sr MD Gl Hd Commodities Mkts
Address
20 S. WACKER DRIVE, CHICAGO
Signature
By: Margaret Austin Wright For: Derek Louis Sammann
Signature date
17 Mar 2026

Reported transactions

CME transaction

Common Stock Class A

Award

Transaction value
Shares
+8,256
Change %
+95%
Price
$311.40*
Shares after
16,939
Date
15 Mar 2026
Ownership
Direct
Footnotes
F1
CME transaction

Common Stock Class A

Tax liability

Transaction value
Shares
-3,627
Change %
-21%
Price
$311.40*
Shares after
13,312
Date
15 Mar 2026
Ownership
Direct
Footnotes
F2
CME holding

Common Stock Class A

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
11,028
Date
15 Mar 2026
Ownership
by Trust
CME holding

Common Stock Class A

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
7,022
Date
15 Mar 2026
Ownership
by Spouse
An asterisk next to the price means the reported price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025.
F2 Mr. Sammann surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .